BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Pedrazzi JFC, Sales AJ, Guimarães FS, Joca SRL, Crippa JAS, Del Bel E. Cannabidiol prevents disruptions in sensorimotor gating induced by psychotomimetic drugs that last for 24-h with probable involvement of epigenetic changes in the ventral striatum. Prog Neuropsychopharmacol Biol Psychiatry 2021;111:110352. [PMID: 34015384 DOI: 10.1016/j.pnpbp.2021.110352] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 3.0] [Reference Citation Analysis]
Number Citing Articles
1 Visini G, Brown S, Weston-green K, Shannon Weickert C, Chesworth R, Karl T. The effects of preventative cannabidiol in a male neuregulin 1 mouse model of schizophrenia. Front Cell Neurosci 2022;16. [DOI: 10.3389/fncel.2022.1010478] [Reference Citation Analysis]
2 Lamtha T, Tabtimmai L, Songtawee N, Tansakul N, Choowongkomon K. Structural analysis of cannabinoids against EGFR-TK leads a novel target against EGFR-driven cell lines. Curr Res Pharmacol Drug Discov 2022;3:100132. [PMID: 36568260 DOI: 10.1016/j.crphar.2022.100132] [Reference Citation Analysis]
3 Reece AS, Hulse GK. Geotemporospatial and causal inferential epidemiological overview and survey of USA cannabis, cannabidiol and cannabinoid genotoxicity expressed in cancer incidence 2003-2017: part 3 - spatiotemporal, multivariable and causal inferential pathfinding and exploratory analyses of prostate and ovarian cancers. Arch Public Health 2022;80:101. [PMID: 35354499 DOI: 10.1186/s13690-022-00813-6] [Cited by in Crossref: 2] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
4 Crunfli F, Brandão-teles C, Zuccoli GS, Chaves Filho AJM, Vieira GM, Silva-amaral D, Crippa JA, Pedrazzi JFC, Macêdo DS, Del-bel E, Gomes FV. What Can We Learn from Animal Models to Study Schizophrenia? Advances in Experimental Medicine and Biology 2022. [DOI: 10.1007/978-3-030-97182-3_2] [Reference Citation Analysis]
5 Filipiuc LE, Ababei DC, Alexa-Stratulat T, Pricope CV, Bild V, Stefanescu R, Stanciu GD, Tamba BI. Major Phytocannabinoids and Their Related Compounds: Should We Only Search for Drugs That Act on Cannabinoid Receptors? Pharmaceutics 2021;13:1823. [PMID: 34834237 DOI: 10.3390/pharmaceutics13111823] [Cited by in Crossref: 11] [Cited by in F6Publishing: 13] [Article Influence: 5.5] [Reference Citation Analysis]
6 Stark T, Di Martino S, Drago F, Wotjak CT, Micale V. Phytocannabinoids and schizophrenia: Focus on adolescence as a critical window of enhanced vulnerability and opportunity for treatment. Pharmacol Res 2021;174:105938. [PMID: 34655773 DOI: 10.1016/j.phrs.2021.105938] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 5.5] [Reference Citation Analysis]